Review



anti-pfak tyr925 (cat# 3284) antibody  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Cell Signaling Technology Inc anti-pfak tyr925 (cat# 3284) antibody
    Anti Pfak Tyr925 (Cat# 3284) Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-pfak tyr925 (cat# 3284) antibody/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    anti-pfak tyr925 (cat# 3284) antibody - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    90
    Cell Signaling Technology Inc anti-pfak tyr925 (cat# 3284) antibody
    Anti Pfak Tyr925 (Cat# 3284) Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-pfak tyr925 (cat# 3284) antibody/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    anti-pfak tyr925 (cat# 3284) antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc anti pfak tyr925
    MPO inhibits prostate cancer metastasis. (A) The cell number of LNCaP cells was counted at different time points. (B, C) Cell cycle analysis through PI staining was detected by FACS (B) , and the cell cycle distribution was presented (C) . (D, E) LNCaP cells were analyzed for cell migration and invasion. Representative images of crystal violet-stained migrated (D) or invaded (E) cells are presented (scale bar, 100 μL). (F) The <t>Tyr925-phosphorylated</t> level of FAK and total FAK, E-Cadherin, and Snail in LNCaP cells were detected by Western blot analysis. Actin was used as a loading control. All data are presented as the mean ± SD of three independent experiments; ns, not significant.
    Anti Pfak Tyr925, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti pfak tyr925/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    anti pfak tyr925 - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc anti pfak y925
    Growth of GBM cells in fibrin clot and plasma clot depends on integrins β1 and β3. A, Integrins β1, β3, β5, and αV as well as total and activated FAK at Y397 and <t>Y925</t> were analyzed in subconfluent extracts from U87MG, U373MG, and U343MG GBM cells by immunoblotting. α-tubulin served as a loading control. B, Western blot analysis of integrin β1 and integrin β3 expression and total FAK and FAK activation at Y925 in extracts from U87MG and U373MG cells 3 days after transfection with siRNA against integrins β1 (siβ1) and β3 (siβ3) compared with treatment with control siRNA (siCtrl; B , top). FAK expression after transfection with siRNA against FAK (siFAK) compared with siCtrl ( B , bottom). C–F, Fold increase in cell proliferation was analyzed over time in fibrin clot–embedded ( C ) and plasma clot–embedded ( D ) U87MG cells and in fibrin clot–embedded ( E ) and plasma clot–embedded ( F ) U373MG cells following transfection with siβ1, siβ3, and siRNA against FAK compared with siCtrl by phase-contrast microscopy. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 compared with siCtrl.
    Anti Pfak Y925, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti pfak y925/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    anti pfak y925 - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc pfak cell signalling
    Growth of GBM cells in fibrin clot and plasma clot depends on integrins β1 and β3. A, Integrins β1, β3, β5, and αV as well as total and activated FAK at Y397 and <t>Y925</t> were analyzed in subconfluent extracts from U87MG, U373MG, and U343MG GBM cells by immunoblotting. α-tubulin served as a loading control. B, Western blot analysis of integrin β1 and integrin β3 expression and total FAK and FAK activation at Y925 in extracts from U87MG and U373MG cells 3 days after transfection with siRNA against integrins β1 (siβ1) and β3 (siβ3) compared with treatment with control siRNA (siCtrl; B , top). FAK expression after transfection with siRNA against FAK (siFAK) compared with siCtrl ( B , bottom). C–F, Fold increase in cell proliferation was analyzed over time in fibrin clot–embedded ( C ) and plasma clot–embedded ( D ) U87MG cells and in fibrin clot–embedded ( E ) and plasma clot–embedded ( F ) U373MG cells following transfection with siβ1, siβ3, and siRNA against FAK compared with siCtrl by phase-contrast microscopy. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 compared with siCtrl.
    Pfak Cell Signalling, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pfak cell signalling/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    pfak cell signalling - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc pfak
    Growth of GBM cells in fibrin clot and plasma clot depends on integrins β1 and β3. A, Integrins β1, β3, β5, and αV as well as total and activated FAK at Y397 and <t>Y925</t> were analyzed in subconfluent extracts from U87MG, U373MG, and U343MG GBM cells by immunoblotting. α-tubulin served as a loading control. B, Western blot analysis of integrin β1 and integrin β3 expression and total FAK and FAK activation at Y925 in extracts from U87MG and U373MG cells 3 days after transfection with siRNA against integrins β1 (siβ1) and β3 (siβ3) compared with treatment with control siRNA (siCtrl; B , top). FAK expression after transfection with siRNA against FAK (siFAK) compared with siCtrl ( B , bottom). C–F, Fold increase in cell proliferation was analyzed over time in fibrin clot–embedded ( C ) and plasma clot–embedded ( D ) U87MG cells and in fibrin clot–embedded ( E ) and plasma clot–embedded ( F ) U373MG cells following transfection with siβ1, siβ3, and siRNA against FAK compared with siCtrl by phase-contrast microscopy. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 compared with siCtrl.
    Pfak, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pfak/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    pfak - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc pfak y925
    Growth of GBM cells in fibrin clot and plasma clot depends on integrins β1 and β3. A, Integrins β1, β3, β5, and αV as well as total and activated FAK at Y397 and <t>Y925</t> were analyzed in subconfluent extracts from U87MG, U373MG, and U343MG GBM cells by immunoblotting. α-tubulin served as a loading control. B, Western blot analysis of integrin β1 and integrin β3 expression and total FAK and FAK activation at Y925 in extracts from U87MG and U373MG cells 3 days after transfection with siRNA against integrins β1 (siβ1) and β3 (siβ3) compared with treatment with control siRNA (siCtrl; B , top). FAK expression after transfection with siRNA against FAK (siFAK) compared with siCtrl ( B , bottom). C–F, Fold increase in cell proliferation was analyzed over time in fibrin clot–embedded ( C ) and plasma clot–embedded ( D ) U87MG cells and in fibrin clot–embedded ( E ) and plasma clot–embedded ( F ) U373MG cells following transfection with siβ1, siβ3, and siRNA against FAK compared with siCtrl by phase-contrast microscopy. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 compared with siCtrl.
    Pfak Y925, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pfak y925/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    pfak y925 - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    Image Search Results


    MPO inhibits prostate cancer metastasis. (A) The cell number of LNCaP cells was counted at different time points. (B, C) Cell cycle analysis through PI staining was detected by FACS (B) , and the cell cycle distribution was presented (C) . (D, E) LNCaP cells were analyzed for cell migration and invasion. Representative images of crystal violet-stained migrated (D) or invaded (E) cells are presented (scale bar, 100 μL). (F) The Tyr925-phosphorylated level of FAK and total FAK, E-Cadherin, and Snail in LNCaP cells were detected by Western blot analysis. Actin was used as a loading control. All data are presented as the mean ± SD of three independent experiments; ns, not significant.

    Journal: Frontiers in Genetics

    Article Title: Exploring the prognostic significance of lactate-mitochondria-related genes in prostate cancer

    doi: 10.3389/fgene.2024.1515045

    Figure Lengend Snippet: MPO inhibits prostate cancer metastasis. (A) The cell number of LNCaP cells was counted at different time points. (B, C) Cell cycle analysis through PI staining was detected by FACS (B) , and the cell cycle distribution was presented (C) . (D, E) LNCaP cells were analyzed for cell migration and invasion. Representative images of crystal violet-stained migrated (D) or invaded (E) cells are presented (scale bar, 100 μL). (F) The Tyr925-phosphorylated level of FAK and total FAK, E-Cadherin, and Snail in LNCaP cells were detected by Western blot analysis. Actin was used as a loading control. All data are presented as the mean ± SD of three independent experiments; ns, not significant.

    Article Snippet: Anti- FAK (Cat# 3285), anti-pFAK Tyr925 (Cat# 3284), anti-Snail (Cat# 3879), anti-E-Cadherin (Cat# 3195) and anti-actin (Cat# 4970) antibodies were purchased from Cell Signaling Technology.

    Techniques: Cell Cycle Assay, Staining, Migration, Western Blot, Control

    Growth of GBM cells in fibrin clot and plasma clot depends on integrins β1 and β3. A, Integrins β1, β3, β5, and αV as well as total and activated FAK at Y397 and Y925 were analyzed in subconfluent extracts from U87MG, U373MG, and U343MG GBM cells by immunoblotting. α-tubulin served as a loading control. B, Western blot analysis of integrin β1 and integrin β3 expression and total FAK and FAK activation at Y925 in extracts from U87MG and U373MG cells 3 days after transfection with siRNA against integrins β1 (siβ1) and β3 (siβ3) compared with treatment with control siRNA (siCtrl; B , top). FAK expression after transfection with siRNA against FAK (siFAK) compared with siCtrl ( B , bottom). C–F, Fold increase in cell proliferation was analyzed over time in fibrin clot–embedded ( C ) and plasma clot–embedded ( D ) U87MG cells and in fibrin clot–embedded ( E ) and plasma clot–embedded ( F ) U373MG cells following transfection with siβ1, siβ3, and siRNA against FAK compared with siCtrl by phase-contrast microscopy. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 compared with siCtrl.

    Journal: Cancer Research Communications

    Article Title: Clotting Promotes Glioma Growth and Infiltration Through Activation of Focal Adhesion Kinase

    doi: 10.1158/2767-9764.CRC-24-0164

    Figure Lengend Snippet: Growth of GBM cells in fibrin clot and plasma clot depends on integrins β1 and β3. A, Integrins β1, β3, β5, and αV as well as total and activated FAK at Y397 and Y925 were analyzed in subconfluent extracts from U87MG, U373MG, and U343MG GBM cells by immunoblotting. α-tubulin served as a loading control. B, Western blot analysis of integrin β1 and integrin β3 expression and total FAK and FAK activation at Y925 in extracts from U87MG and U373MG cells 3 days after transfection with siRNA against integrins β1 (siβ1) and β3 (siβ3) compared with treatment with control siRNA (siCtrl; B , top). FAK expression after transfection with siRNA against FAK (siFAK) compared with siCtrl ( B , bottom). C–F, Fold increase in cell proliferation was analyzed over time in fibrin clot–embedded ( C ) and plasma clot–embedded ( D ) U87MG cells and in fibrin clot–embedded ( E ) and plasma clot–embedded ( F ) U373MG cells following transfection with siβ1, siβ3, and siRNA against FAK compared with siCtrl by phase-contrast microscopy. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 compared with siCtrl.

    Article Snippet: The membrane was blocked with 5% non-fat dry milk or 5% BSA in PBS containing 0.1% Tween 20 for 1 hour at room temperature and probed for anti-integrin β1 (Cell Signaling Technology, catalog # 9699, RRID: AB_11178800), anti-integrin β3 (BD Biosciences, catalog # 611140, RRID: AB_398451), anti-integrin β5 (Cell Signaling Technology, catalog # 3629, RRID: AB_2249358), anti-integrin αV (BD Biosciences, catalog # 611012, RRID: AB_398325), anti-FAK (Cell Signaling Technology, catalog # 3285, RRID: AB_2269034), anti-pFAK Y397 (Thermo Fisher Scientific, catalog # 700255, RRID: AB_2532307), anti-pFAK Y925 (Cell Signaling Technology, catalog # 3284, RRID: AB_10831810), or α-tubulin (Sigma-Aldrich, catalog # T-6199, RRID: AB_477583) overnight at 4°C.

    Techniques: Clinical Proteomics, Western Blot, Control, Expressing, Activation Assay, Transfection, Microscopy